Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Longhi

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Annals of Surgical Oncology|June 24, 2020
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma GroupAnna Paioli, Silvia Stacchiotti, Domenico Campanacci, et al.
Cells|November 4, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective SeriesEmanuela Palmerini, Elisabetta Setola, Giovanni Grignani, et al.
Frontiers in Oncology|October 25, 2023
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case reportEmanuela Palmerini, Giorgio Frega, Marco Gambarotti, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Tumori|August 9, 2018
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary resultsEmanuela Palmerini, Pietro Ruggieri, Andrea Angelini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma GroupAlessandro Gronchi, Sergio Frustaci, Mario Mercuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2005
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma GroupsStefano Ferrari, Sigbjorn Smeland, Mario Mercuri, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Annals of Surgical Oncology|June 24, 2020
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma GroupAnna Paioli, Silvia Stacchiotti, Domenico Campanacci, et al.
Cells|November 4, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective SeriesEmanuela Palmerini, Elisabetta Setola, Giovanni Grignani, et al.
Frontiers in Oncology|October 25, 2023
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case reportEmanuela Palmerini, Giorgio Frega, Marco Gambarotti, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2022
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Tumori|August 9, 2018
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary resultsEmanuela Palmerini, Pietro Ruggieri, Andrea Angelini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma GroupAlessandro Gronchi, Sergio Frustaci, Mario Mercuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2005
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma GroupsStefano Ferrari, Sigbjorn Smeland, Mario Mercuri, et al.
Pageof 11